Navigation Links
A grim dilemma: Treating the tortured prisoner
Date:5/9/2011

outweighed by other factors, such as the tortured prisoner's desire for treatment. They argue that dilemmas facing physicians arise because different principles, such as refraining from doing harm and respecting a patient's wishes, come in conflict with each other. As a result, they write, "This dilemma is real and . . . sometimes the right thing for a doctor to do, overall, is to be complicit in torture."

The authors provide guidelines to physicians for minimizing complicity, including assessing the consequences of their actions for themselves, the patient, and possibly society, and attempting to discern and follow the requests of the patient. Physicians can minimize complicity by ensuring that their actions do not share the wrongful intentions of the torturers and that they perform the physician role in such a way at to "mitigate, prevent, or help redress acts of torture." For example, a physician could secretly collect data to be used by groups investigating torture. The authors note that physicians who have been coerced into assisting with torture have often been among the first sources for international tribunals redressing the torture.

Despite their recommendations for individual physicians, the authors do not endorse altering professional and legal prohibitions against physician involvement in torture, because these powerful condemnations offer aspiration to a world without torture and they can help doctors avoid involvement. But the authors do recommend a case-by-case approach to enforcement that considers the challenges and ethical complexities for physicians in countries where torture is widespread, as well as the willingness of some doctors to compromise themselves for the sake of their patients.

"Other things being equal, it is better for a physician not to be complicit in torture," the authors conclude. "But other things are rarely equal and . . . a physician ought sometimes to accept complicity in torture for other moral r
'/>"/>

Contact: Michael Turton
turtonm@thehastingscenter.org
845-424-4040 x242
The Hastings Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Day care dilemma: When sick children are unnecessarily sent home
2. Blood Draw Dilemma: New Summit Health Article Helps Employers Choose the Best Screening Method
3. Treating Kids for Environmental Ills Costs U.S. $76B a Year
4. Animal studies reveal new route to treating heart disease
5. New gene therapy technique on iPS cells holds promise in treating immune system disease
6. NIH study finds Avastin and Lucentis are equally effective in treating AMD
7. Possible new approach to treating deadly leukemia in babies
8. Experts issue recommendations for evaluating and treating pituitary incidentalomas
9. Treating newborn horses: A unique form of pediatrics
10. Cancer drug shows promise for treating scleroderma
11. Weight-loss surgery successful in treating overweight adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... (DaWei Induction Heating Co.) is a comprehensive high-tech business ... of a series of induction heating equipment. Today, the ... induction brazing equipments . , According to a ... refers to the joining of two or more components ... says that there are fundamental differences in the two ...
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... current state of the global Sterilizers industry with a ... statistics on the market status of the Sterilizers manufacturers ... for companies and individuals interested in the industry. This ... its definition, applications and manufacturing technology. In this part, ...
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – ... current treatment landscape, unmet needs, current pipeline and commercial ... anti-cancer drug which is typically used for treating colorectal ... for treating gastric cancer and pancreatic cancer. TS-1 is ... was first approved in 1999 in Japan for the ...
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding ... new selection of black one-shoulder cocktail dresses . In ... are available at discounted prices, up to 70% off. ... for three weeks only. You know, we have thousands of ... in our new items can visit our website for more ...
(Date:12/25/2014)... 2014 Recently, BellasDress has ... its wedding dresses. BellasDress has chosen their best-selling lace ... choices for the holiday season. , Now, BellasDress.com ... wedding gowns here at discount prices. The business hopes ... its website. , “All our elegant products ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
... /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE:,MDZ), a leading provider ... hold its 2008 Annual Investor Day on February 21,2008 at ... will provide 2008 financial guidance as part of the Investor ... are invited to,listen to the live webcast of the MDS ...
... reports of high mercury,content in tuna sampled from New ... about the health benefits,versus the safety of the fish ... consume the recommended 12 ounces of fish a week ... any risk of contamination,from mercury or other pollutants., ...
... Calif., Feb. 14 Genoptix, Inc.,(Nasdaq: GXDX ), ... the Securities and Exchange Commission for a proposed secondary ... of common stock to,be registered are currently owned and ... will receive all of the net proceeds from this,offering. ...
... MELVILLE, N.Y., Feb. 14 Gentiva Health,Services, Inc. (Nasdaq: GTIV ... today reported the,following financial results for the fourth quarter ended December ... to $313.4 million versus the fourth quarter ... $8.8 million, or $0.31 per diluted share, versus ...
... Day has,always conjured up images of eager boyfriends and ... Love You." Over the decades, women have,become better able ... rather than simply accepting generic and, sometimes,short lived gifts ... Carl and Kristina of suburban Chicago. After,twelve years of ...
... main metabolite of the insecticide DDT could be associated ... no explanation for this observation to date. Now a ... Research shows how DDT could act to disrupt hormone-sensitive ... Universite Laval and Institut national de sante publique in ...
Cached Medicine News:Health News:Ongoing Tests Show Kona Kampachi(R) is Rich in Omega-3s With No Detectable Mercury 2Health News:Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock 2Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 2Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 3Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 4Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 5Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 6Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 7Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 8Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 9Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 10Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 11Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 12Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 13Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 14Health News:Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook 15Health News:St. Valentine's Day Wishes: Perfume? Jewelry? Labiaplasty? 2Health News:How DDT metabolite disrupts breast cancer cells 2
(Date:12/24/2014)... Ohio , Dec. 23, 2014   ... treatment decision support to healthcare providers for behavioral ... it has secured $30 million in equity financing ... Virginia C. Drosos , President and Chief Executive ... clinical adoption and development of Assurex Health,s ...
(Date:12/24/2014)... N.C. , Dec. 23, 2014  Endo Pharmaceuticals ... ENDP ) (TSX: ENL), and BioDelivery Sciences International, ... they have submitted a New Drug Application (NDA) for ... Drug Administration (FDA).  Buprenorphine HCl Buccal Film is under ... require daily, around-the-clock, long-term opioid treatment and for which ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... the "US Self-monitoring Blood Glucose Market" report ... This market insight focuses on the ... the United States . Reimbursement analysis and ... product analyses for more than 73 SMBG meters have ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5US Self-monitoring Blood Glucose Market 2
... , CARY, N.C., Nov. 20 Cornerstone Therapeutics Inc. ... on acquiring, developing and commercializing significant products primarily for ... had received a Warning Letter from the Food and ... tablets (Phenylephrine HCl 10 mg, Pyrilamine Maleate 16 mg) ...
... , HARRISBURG, Pa., Nov. 20 The Department ... priority groups that did not have previous access to the vaccine. , ... Friday,s clinic hours are from 2 p.m. to 8 p.m. Hours on ... Nov. 22, the clinics will operate from 2 p.m. to 8 p.m. ...
Cached Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: